NDAINTRAVENOUSPOWDER
Approved
Oct 2018
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
12.1 Mechanism of Action High-Dose Methotrexate Therapy Levoleucovorin is the pharmacologically active isomer of 5-formyl tetrahydrofolic acid. Levoleucovorin does not require reduction by dihydrofolate reductase to participate in reactions utilizing folates as a source of "one-carbon" moieties.…
Indications (1)
Loss of Exclusivity
LOE Date
Mar 25, 2039
158 months away
Patent Expiry
Mar 25, 2039
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 11541012 | Mar 25, 2039 | Product | — |